S&P 500   4,455.48
DOW   34,798.00
QQQ   373.33
S&P 500   4,455.48
DOW   34,798.00
QQQ   373.33
S&P 500   4,455.48
DOW   34,798.00
QQQ   373.33
S&P 500   4,455.48
DOW   34,798.00
QQQ   373.33

STRATA Skin Sciences Stock Forecast, Price & News

+0.06 (+3.30 %)
(As of 09/24/2021 12:00 AM ET)
Today's Range
50-Day Range
52-Week Range
Volume99,034 shs
Average Volume279,283 shs
Market Capitalization$63.95 million
P/E RatioN/A
Dividend YieldN/A
30 days | 90 days | 365 days | Advanced Chart
Receive SSKN News and Ratings via Email

Sign-up to receive the latest news and ratings for STRATA Skin Sciences and its competitors with MarketBeat's FREE daily newsletter.

STRATA Skin Sciences logo

About STRATA Skin Sciences

STRATA Skin Sciences, Inc. is a medical technology company in Dermatology and Plastic Surgery. It engages in developing, commercializing and marketing products for the treatment of dermatologic conditions. The firm operates through the following segments: Dermatology Recurring Procedures and Dermatology Procedures Equipment. The Dermatology Recurring Procedures segment derives its revenues from the usage of its equipment by dermatologists to perform XTRAC procedures. The Dermatology Procedures Equipment segment generates revenues from the sale of equipment, such as lasers and lamp products. The company was founded by Dina Gutkowicz-Krusin in December 1989 and is headquartered in Horsham, PA.


See More Headlines

Industry, Sector and Symbol

Sales & Book Value





Social Links


Overall MarketRank

2.04 out of 5 stars

Medical Sector

516th out of 1,351 stocks

Surgical & Medical Instruments Industry

53rd out of 123 stocks

Analyst Opinion: 3.5Community Rank: 4.4Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 0.6 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles

STRATA Skin Sciences (NASDAQ:SSKN) Frequently Asked Questions

Is STRATA Skin Sciences a buy right now?

1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for STRATA Skin Sciences in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" STRATA Skin Sciences stock.
View analyst ratings for STRATA Skin Sciences
or view top-rated stocks.

What stocks does MarketBeat like better than STRATA Skin Sciences?

Wall Street analysts have given STRATA Skin Sciences a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but STRATA Skin Sciences wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting STRATA Skin Sciences?

STRATA Skin Sciences saw a decline in short interest during the month of August. As of August 13th, there was short interest totaling 142,700 shares, a decline of 16.6% from the July 29th total of 171,200 shares. Based on an average daily trading volume, of 63,300 shares, the days-to-cover ratio is currently 2.3 days. Approximately 0.7% of the company's shares are short sold.
View STRATA Skin Sciences' Short Interest

When is STRATA Skin Sciences' next earnings date?

STRATA Skin Sciences is scheduled to release its next quarterly earnings announcement on Tuesday, November 9th 2021.
View our earnings forecast for STRATA Skin Sciences

How were STRATA Skin Sciences' earnings last quarter?

STRATA Skin Sciences, Inc. (NASDAQ:SSKN) issued its quarterly earnings results on Monday, August, 16th. The medical device company reported $0.03 EPS for the quarter, topping the Zacks' consensus estimate of ($0.05) by $0.08. The medical device company earned $7.38 million during the quarter, compared to analyst estimates of $6.46 million. STRATA Skin Sciences had a negative trailing twelve-month return on equity of 19.90% and a negative net margin of 11.88%.
View STRATA Skin Sciences' earnings history

How has STRATA Skin Sciences' stock price been impacted by Coronavirus (COVID-19)?

STRATA Skin Sciences' stock was trading at $1.42 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, SSKN shares have increased by 32.4% and is now trading at $1.88.
View which stocks have been most impacted by COVID-19

When did STRATA Skin Sciences' stock split? How did STRATA Skin Sciences' stock split work?

STRATA Skin Sciences shares reverse split before market open on Thursday, July 10th 2014. The 1-10 reverse split was announced on Thursday, July 3rd 2014. The number of shares owned by shareholders was adjusted after the closing bell on Wednesday, July 9th 2014. An investor that had 100 shares of STRATA Skin Sciences stock prior to the reverse split would have 10 shares after the split.

What price target have analysts set for SSKN?

1 brokers have issued twelve-month target prices for STRATA Skin Sciences' stock. Their forecasts range from $3.00 to $3.00. On average, they anticipate STRATA Skin Sciences' stock price to reach $3.00 in the next twelve months. This suggests a possible upside of 59.6% from the stock's current price.
View analysts' price targets for STRATA Skin Sciences
or view top-rated stocks among Wall Street analysts.

Who are STRATA Skin Sciences' key executives?

STRATA Skin Sciences' management team includes the following people:
  • Robert J. Moccia, President, Chief Executive Officer & Director
  • Matthew C. Hill, Chief Financial Officer
  • Brent Cowgill, Vice President-Marketing
  • Jay Sturm, Secretary & General Counsel

What other stocks do shareholders of STRATA Skin Sciences own?

Based on aggregate information from My MarketBeat watchlists, some companies that other STRATA Skin Sciences investors own include Trevena (TRVN), Amarin (AMRN), Biocept (BIOC), Kopin (KOPN), OPKO Health (OPK), Plug Power (PLUG), AbbVie (ABBV), SCYNEXIS (SCYX), Tonix Pharmaceuticals (TNXP) and Agile Therapeutics (AGRX).

What is STRATA Skin Sciences' stock symbol?

STRATA Skin Sciences trades on the NASDAQ under the ticker symbol "SSKN."

Who are STRATA Skin Sciences' major shareholders?

STRATA Skin Sciences' stock is owned by a variety of retail and institutional investors. Top institutional shareholders include 22NW LP (4.36%), Renaissance Technologies LLC (3.86%), Cannell Capital LLC (2.55%) and Vanguard Group Inc. (2.37%).
View institutional ownership trends for STRATA Skin Sciences

Which major investors are selling STRATA Skin Sciences stock?

SSKN stock was sold by a variety of institutional investors in the last quarter, including Cannell Capital LLC, and Renaissance Technologies LLC.
View insider buying and selling activity for STRATA Skin Sciences
or view top insider-selling stocks.

Which major investors are buying STRATA Skin Sciences stock?

SSKN stock was bought by a variety of institutional investors in the last quarter, including 22NW LP, and Vanguard Group Inc..
View insider buying and selling activity for STRATA Skin Sciences
or or view top insider-buying stocks.

How do I buy shares of STRATA Skin Sciences?

Shares of SSKN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is STRATA Skin Sciences' stock price today?

One share of SSKN stock can currently be purchased for approximately $1.88.

How much money does STRATA Skin Sciences make?

STRATA Skin Sciences has a market capitalization of $63.95 million and generates $23.09 million in revenue each year. The medical device company earns $-4,410,000.00 in net income (profit) each year or ($0.13) on an earnings per share basis.

How many employees does STRATA Skin Sciences have?

STRATA Skin Sciences employs 109 workers across the globe.

What is STRATA Skin Sciences' official website?

The official website for STRATA Skin Sciences is www.strataskinsciences.com.

Where are STRATA Skin Sciences' headquarters?

STRATA Skin Sciences is headquartered at 5 WALNUT GROVE DRIVE SUITE 140, HORSHAM PA, 19044.

How can I contact STRATA Skin Sciences?

STRATA Skin Sciences' mailing address is 5 WALNUT GROVE DRIVE SUITE 140, HORSHAM PA, 19044. The medical device company can be reached via phone at (215) 619-3200 or via email at [email protected].

This page was last updated on 9/25/2021 by MarketBeat.com Staff


Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.